PRICE T ROWE ASSOCIATES INC /MD/

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$112,098

+$93,469 QoQ

Shares Held

10,758

+1094.0% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 95 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. RNAC ranks #279 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$112,098	10,758	-60.2%	Shares	Defined	2026-08-14
2023-12-31	$18,629	27,039	+14.3%	Shares	Defined	2024-02-16
2023-09-30	$25,074	23,655	-48.0%	Shares	Defined	2023-11-14
2023-06-30	$50,920	45,465	+108.5%	Shares	Defined	2023-08-14
2023-03-31	$30,315	21,810	0.0%	Shares	Defined	2023-05-15
2022-12-31	$24,645	21,810	0.0%	Shares	Defined	2023-02-14
2022-09-30	$35,768	21,810	0.0%	Shares	Defined	2022-11-14
2022-06-30	$28,571	21,810	+25.7%	Shares	Sole	2022-08-15
2022-03-31	$21,335	17,346	+24.4%	Shares	Sole	2022-05-16
2021-12-31	$45,463	13,946	-9.1%	Shares	Sole	2022-02-14
2021-09-30	$63,851	15,349	+5.1%	Shares	Sole	2021-11-15
2021-06-30	$61,069	14,610	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.